Robeco Institutional Asset Management B.V. Cuts Stock Position in CVS Health Co. (NYSE:CVS)

Robeco Institutional Asset Management B.V. trimmed its position in shares of CVS Health Co. (NYSE:CVS) by 3.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 470,297 shares of the pharmacy operator’s stock after selling 16,681 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in CVS Health were worth $29,572,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Livelsberger Financial Advisory purchased a new stake in CVS Health during the 3rd quarter worth approximately $31,000. Reston Wealth Management LLC acquired a new position in shares of CVS Health in the third quarter worth $32,000. First Community Trust NA raised its stake in shares of CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after acquiring an additional 302 shares in the last quarter. Kathleen S. Wright Associates Inc. purchased a new position in CVS Health in the third quarter valued at $33,000. Finally, ORG Partners LLC boosted its stake in shares of CVS Health by 11,840.0% in the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after buying an additional 592 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Up 1.2 %

CVS opened at $55.33 on Wednesday. CVS Health Co. has a 52 week low of $52.77 and a 52 week high of $83.25. The business has a 50 day moving average price of $59.51 and a two-hundred day moving average price of $59.29. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. The company has a market cap of $69.60 billion, a PE ratio of 9.85, a P/E/G ratio of 0.82 and a beta of 0.55.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.73 by $0.10. The firm had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period last year, the company earned $2.21 earnings per share. As a group, research analysts anticipate that CVS Health Co. will post 6.41 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.81%. The ex-dividend date was Monday, October 21st. CVS Health’s payout ratio is 47.33%.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft reduced their target price on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Wells Fargo & Company reduced their price objective on shares of CVS Health from $61.00 to $60.00 and set an “equal weight” rating on the stock in a report on Monday. Evercore ISI boosted their target price on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Mizuho decreased their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a report on Tuesday, October 1st. Nine investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $73.11.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.